The University of Amsterdam (UvA)’s Faculty of Science, UvA Ventures Holding B.V. and Innovation Exchange Amsterdam (IXA-UvA) are pooling their resources to fund Macrobian Biotech BV, a single asset biotech company that will further develop medicine for the treatment of Parkinson’s disease.

Budget Commissioner Günther Oettinger pleads with governments to reverse proposed €500M cut to next year’s Horizon 2020 budget next year saying, “If you are not prepared to invest in 2018, you will have to invest more in 2019 and 2020”

An assessment of the European Research Council’s outputs says 73 per cent represent breakthroughs or major advances

With its teaching licence revoked and the forced removal from its premises, the European University in St Petersburg is on life support. “We have lost virtually everything,” says one of its professors

The centrepiece of Framework Programme 9 is to be ten moonshot projects that inspire the public and connect people to EU R&D. Researchers are starting to pitch in with their ideas

Clinical trials are fundamental to the development of new treatments for cancer, but annual accrual to studies worldwide is low, at an estimated at three to five percent.

Paying hospitals for activity provides no incentive to improve. Using historical data, patients awaiting cardiac surgery can be profiled, with hospitals paid extra to bear the risk of complications, but receiving no further payment if a second operation is required